Dry eye disease
Drug research and approvals for dry eye disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 158 studies of dry eye disease are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and the EU has 2 authorised medicines for it.
- Recruiting worldwide: 158
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 2
Recruiting Now
Newest start dates first, of 158 recruiting on ClinicalTrials.gov ↗- Pain Phenotyping of Rheumatic Diseases - An Observational StudyNCT07829497 · Not reported · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · starts Nov 9, 2026
- Effectiveness Study of TRYPTYR in Dry Eye DiseaseNCT07926594 · Not reported · Scott & Christie and Associates, PC · starts Oct 27, 2026
- Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye DiseaseNCT05865379 · Not applicable · TRB Chemedica International SA · starts Oct 26, 2026
- BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialNCT07778888 · Phase 2 · Bausch & Lomb Incorporated · starts Oct 19, 2026
- A Study of ATG-201 in Adult Participants With Autoimmune DiseasesNCT07732309 · Phase 1 · Antengene Biologics Limited · starts Sep 26, 2026
- UNITY DX Cornea StudyNCT07768735 · Not reported · Alcon Research · starts Sep 24, 2026
- A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it…NCT07649265 · Phase 1 · Otsuka Pharmaceutical Development & Commercialization, Inc. · starts Sep 24, 2026
- A Multi Center Evaluation of TearCare on Surgical Measurements Before Cataract SurgeryNCT07928986 · Not reported · Cleveland Eye Clinic · starts Sep 22, 2026
- Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease ManagementNCT07842536 · Not applicable · The Hong Kong Polytechnic University · starts Sep 14, 2026
- Evaluation of LacrifillNCT07796178 · Phase 4 · Eye Research Associates, LLC · starts Sep 2, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Nov 30, 2023 | A randomized, double-masked, vehicle-controlled parallel clinical trial to assess efficacy and safety of 0.25% reproxalap ophthalmic solution compared to…REPROXALAP (ADX-102) | Aldeyra Therapeutics, Inc. | Closed |
| Mar 7, 2022 | A randomized, double-masked, vehicle-controlled crossover clinical trial to assess efficacy and safety of 0.25% reproxalap ophthalmic solution compared to…REPROXALAP (ADX-102) | Aldeyra Therapeutics, Inc. | Closed |
| Aug 19, 2021 | A multi-center, vehicle-controlled, randomized study to evaluate the safety, tolerability, systemic pharmacokinetics, and pharmacodynamics of azr-md-001 in…SELENIUM (AZR-MD-001) | AZURA OPHTHALMICS | Closed |
| Aug 10, 2021 | An exploratory single-center, double-masked, crossover clinical trial to assess safety and tolerability of 0.25% reproxalap ophthalmic solution compared to…REPROXALAP (ADX-102) | DR. PETER COUROUX | Closed |
| Jan 16, 2015 | A multi-center, double-masked, randomized, one-year safety study of ebi-005 5 mg/ml topical opthalmic solution versus vehicle-control in subjects with dry eye…EBI-005 | ELEVEN BIOTHERAPEUTICS INC | Ongoing |
Medicines Authorised in the EU
Newest first| Sep 19, 2024 | Vevizyeciclosporin | Laboratoires Théa | EMA ↗ |
| Mar 19, 2015 | Ikervisciclosporin | Santen Oy | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA